These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2439803)

  • 1. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
    Lammers JW; Folgering HT; van Herwaarden CL
    Eur J Clin Pharmacol; 1984; 27(2):141-5. PubMed ID: 6149939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients.
    Lammers JW; Folgering HT; van Herwaarden CL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S69-73. PubMed ID: 2439802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1/beta 2-splitting of bisoprolol.
    Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH; McNeill AJ; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
    Pujet JC; Dubreuil C; Fleury B; Provendier O; Abella ML
    Eur Respir J; 1992 Feb; 5(2):196-200. PubMed ID: 1348481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension in mild asthmatic patients with atenolol.
    Krauss S; Spitz E; Krauss A; Grizotzki B; Clement S
    Angiology; 1984 Dec; 35(12):773-8. PubMed ID: 6507943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
    Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioselectivity of cetamolol compared with atenolol and nadolol.
    Klausner MA; Ventura DF; Coelho J; Mullane JF; Irwin C; Hitzenberger G; Magometschnigg D; Kaik G; Garg DC; Weidler DJ
    J Clin Pharmacol; 1988 Jun; 28(6):495-504. PubMed ID: 2901435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.